Delivery Order SPE2DB25D7060-SPE2DB25FXSTL
Award Date 9/9/25
Potential Completion Date 9/30/25
Potential Value $6.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $9,925.98 to AmerisourceBergen Drug Corp for ProQuad vials under a firm fixed price contract. The order was competitively awarded without a set-aside designation and is scheduled for completion by May 23, 2025. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and varicella, making this a critical pharmaceutical supply for military healthcare operations. AmerisourceBergen, headquartered in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of ProQuad vials with a ceiling value of $16,543.30 and ultimate completion date of September 29, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $8,354.50 under a firm fixed-price contract. The award was made on July 25, 2025, with an ultimate completion date of August 15, 2025. This is a non-set-aside, competitively awarded delivery order, with performance to take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $1,687.48, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is located in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency valued at $1,654.33 for ProQuad vials. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 5, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,687.48 on August 29, 2025, for ProQuad vials, with an ultimate completion date of September 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $16,543.30 for ProQuad vials under a Defense Logistics Agency contract. The award, issued on September 2, 2025, with completion targeted for September 23, 2025, employs firm fixed-price terms with no set-aside designation. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and varicella, making this delivery order a component of the federal...
- The Defense Logistics Agency awarded a $2,686.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ProQuad vials on August 14, 2025, with an ultimate completion date of September 5, 2025. This contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. ProQuad is a combination vaccine protecting against measles, mumps, rubella, and...
- The Defense Logistics Agency awarded a $5,426.92 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract contains no set-aside designation and will be performed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for ProQuad vials valued at $6,683.60 by the Defense Logistics Agency (DLA). The contract, awarded on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...